Clinical Trial Update: Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration

View source ↗

Summary

An observational study assessing the incidence of nephrogenic systemic fibrosis in patients with renal impairment after administration of Dotarem (gadoterate me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Nephrogenic Systemic Fibrosis

Drugs mentioned

• DOTAREM (Gadoterate meglumine)

Snippet

Sponsor: Guerbet | Conditions: Renal Insufficiency | Status: COMPLETED | Results posted: 2019-02-04